Activity Preview

Live

FOCUS Quiz: Spring 2019 - The Changing Landscape of Substance Use Disorders

Activity Type:

  • Journal CME


Release Date: 4/1/2019

Expiration Date: 12/31/2021

  • AMA PRA Category 1: 5
  • Participation: 5

Access Activity

Overview

The Changing Landscape of Substance Use Disorders

FOCUS, APA's clinical review and continuing medical education journal, is designed as a personal study resource to help practicing psychiatrists keep abreast of significant advances in the field, with particular attention to clinical practice and incorporation of core competencies. The goal of FOCUS is the dissemination of up-to-date clinical information, facilitation of lifelong learning skills, maintenance of certification, and opportunity for self-assessment in order to improve patient care. Each issue, prepared by distinguished faculty who are recognized in their fields, provides up to date clinical information and incorporates a CME component. The material can be used effectively by establishing a regular schedule of study.

Pricing

This activity is only available to 2019 Focus subscribers.

Don't have a subscription to 2019 Focus? Subscribe online or by phone at 1-800-368-5777.  

If you have questions about Focus subscriptions, please contact appi@psych.org.

Educational Objectives

This issue of Focus provides the reader with a current view of the nation’s substance use crisis and treatments for substance use disorders.

Participants will:

  • review the scope of the opioid crisis and governmental efforts to combat the growing epidemic
  • identify effective treatment strategies for a range of substance use disorders
  • identify delivery systems for intermediate- to long-acting buprenorphine maintenance treatment  options
  • be up to date concerning epidemiology and treatment of cannabis use disorder
  • explore treatment recommendations for co-occurring substance use disorders and other psychiatric conditions

Target Audience

This program is one element of a lifelong learning program for psychiatrists and is an aid for psychiatrists and other clinicians participating in maintenance of certification.

Estimated Time to Complete

Estimated Duration: 5 hours
Begin Date: April 1, 2019
End Date: December 31, 2021

How to Earn Credit

In order to earn CME credit, participants should read through the material presented in the issue. After reading the materials, complete the CME quiz by answering multiple-choice questions with a single correct answer. A score of 60% or higher is required to receive credit. Retakes are available for the test. Review the rationales, complete the online course evaluation, and then claim and print your CME certificate. The APA provides a CME certificate of credit for physicians and a certificate of participation for non-physicians.

Continuing Education Credit

The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The APA designates this journal-based CME activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Program Planners – Editor and Associate Editors

Mark H. Rapaport, M.D., Editor of FOCUS, and Chairman and Chief of Psychiatric Services, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA. Reports no financial relationships with commercial interests.

Dorothy Stubbe, M.D., Editor and Author, Communications Commentary, Associate Professor and Program Director, Yale University School of Medicine Child Study Center, New Haven, CT. Reports no financial relationships with commercial interests.

Laura Dunn, M.D., Co-Editor Ethics Column; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA. Dr. Dunn discloses the following relationship: Consultant: Otsuka America Pharmaceutical Inc.

Substance Use Among College Students

Justine W. Welsh, M.D., Yujia Shentu, M.S., Dana B. Sarvey, M.D. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Welsh, Shentu); Adolescent Acute Residential Treatment, McLean Hospital, Harvard Medical School, Belmont, Massachusetts (Sarvey). Dr. Welsh reports receipt of consulting fees from GW Pharmaceuticals and training fees from Chestnut Health Systems. The other authors report no financial relationships with commercial interests.

The Assessment And Management Of Endocarditis Among People Who Inject Drugs In The General Hospital Setting

Joji Suzuki M.D., Department of Psychiatry, Brigham and Women’s Hospital, Boston, MA, Harvard Medical School, Boston, MA. Reports no financial relationships with commercial interests

Psychiatry and the Opioid Overdose Crisis

Bertha K. Madras, Ph.D., and Hilary Connery, M.D., Ph.D., Substance Use Disorders Division, McLean Hospital, Belmont, MA, and Department of Psychiatry, Harvard Medical School, Boston. The authors report no financial relationships with commercial interests.

Treatment for Substance Use Disorder with Co-Occurring Mental Illness

Muhammad N Iqbal, M.D., Charles J. Levin, B.A.  New York State Psychiatric Institute, Division on Substance Use Disorders; Frances R. Levin, M.D., New York State Psychiatric Institute, Division on Substance Use Disorders, College of Physicians and Surgeons of Columbia University, New York, NY. Muhammad N. Iqbal and Charles J. Levin report no financial relationships with commercial interests.  Frances R. Levin serves as a consultant to Major League Baseball regarding the diagnosis and treatment of attention deficit/hyperactivity disorder.

Cannabis and the Current State of Treatment for Cannabis Use Disorder

Arthur Robin Williams, M.D., MBE, Division on Substance Use Disorders, Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, Kevin P. Hill, M.D., M.H.S.Division of Addiction Psychiatry, Beth Israel DeaconessMedical Center, and Department of Psychiatry, Harvard Medical School,Boston. Dr. Williams reports no financial relationships with commercial interests. Dr. Hill reports receipt of royalties from Hazelden Publishing.

Novel Formulations of Buprenorphine for Treatment of Opioid Use Disorder

Richard N. Rosenthal, M.D., Department of Psychiatry and Behavioral Health, Health Sciences Center, Renaissance School of Medicine at Stony Brook University. Dr. Rosenthal reports receiving consulting fees and support for continuing medical education from Molteni Farma.

Substance Use Among Older Adults: Ethical Issues

Chinyere I. Ogbonna, M.D., M.P.H., and Anna Lembke, M.D,. Department of Psychiatry and Behavioral Sciences (Ogbonna, Lembke) and Addiction Medicine (Lembke), Stanford University School of Medicine, Stanford, California; Kaiser Permanente San Jose Addiction MedicineServices, San Jose, California (Ogbonna). The authors report no financial relationships with commercial interests.

Counteracting the Effect of Stigma on Education for Substance Use Disorders

John A. Renner, Jr., M.D., Department of Psychiatry, Boston University School of Medicine, Boston, and VA Outpatient Clinic, Boston. Dr. Renner reports receipt of publishing royalties from American Psychiatric Association Publishing.

Management of Adolescent Substance Use Disorders, With an Emphasis on Cannabis

Jeffery N. Wilkins, M.D., LINCY-Heyward/Moynihan Inaugural Chair in Addiction Medicine, Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles. Dr. Wilkins reports no financial relationships with commercial interests.

American Psychiatric Association Staff Involved in Planning:  

Tristan Gorrindo, M.D., Director, Division of Education, APA. Reports no financial relationships with commercial interests.

Kristen Moeller, Director of CME, Associate Director of FOCUS. Reports no financial relationships with commercial interests.

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

  • Flash Player: Adobe Flash Player 10.1+ 
  • Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+ 
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera

Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

For assistance: Contact educme@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance

Access Activity